Clinical Pharmacogenetic Testing and the Posttest Counseling Conundrum

Clin Pharmacol Ther. 2020 Nov;108(5):924-928. doi: 10.1002/cpt.1913. Epub 2020 Jun 27.

Authors

Robert Rigobello¹, Shahad Rahawi¹, Richard Wallsten¹, Neal Cody^{1

2}, Paola Nicoletti^{1

2}, Aniwaa Owusu Obeng^{2

3}, Hetanshi Naik², Mitchell W Dillon², Stuart A Scott^{1

2}

Affiliations

¹ Sema4, Stamford, Connecticut, USA.
² Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
³ Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

PMID: 32592592
DOI: 10.1002/cpt.1913

No abstract available

MeSH terms

Clinical Competence
Genetic Counseling*
Health Services Accessibility
Humans
Licensure
Pharmacogenetics
Pharmacogenomic Testing*
Pharmacogenomic Variants*
Predictive Value of Tests